Publication Information

{'id': 'https://openalex.org/W2954278871', 'doi': 'https://doi.org/10.1136/annrheumdis-2019-eular.1206', 'title': 'SAT0635 PATIENT-PERCEIVED RESIDUAL BURDEN OF PSORIATIC ARTHRITIS IN PATIENTS IN REMISSION/LOW DISEASE: AN ANALYSIS OF 444 PATIENTS', 'display_name': 'SAT0635 PATIENT-PERCEIVED RESIDUAL BURDEN OF PSORIATIC ARTHRITIS IN PATIENTS IN REMISSION/LOW DISEASE: AN ANALYSIS OF 444 PATIENTS', 'publication_year': 2019, 'publication_date': '2019-05-27', 'ids': {'openalex': 'https://openalex.org/W2954278871', 'doi': 'https://doi.org/10.1136/annrheumdis-2019-eular.1206', 'mag': '2954278871'}, 'language': 'en', 'primary_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1136/annrheumdis-2019-eular.1206', 'pdf_url': 'https://ard.bmj.com/content/annrheumdis/78/Suppl_2/1415.1.full.pdf', 'source': None, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'type': 'article', 'type_crossref': 'proceedings-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': True, 'oa_status': 'bronze', 'oa_url': 'https://ard.bmj.com/content/annrheumdis/78/Suppl_2/1415.1.full.pdf', 'any_repository_has_fulltext': True}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5091895459', 'display_name': 'Laure Gossec', 'orcid': 'https://orcid.org/0000-0002-4528-310X'}, 'institutions': [], 'countries': ['FR'], 'is_corresponding': False, 'raw_author_name': 'Laure Gossec', 'raw_affiliation_strings': ['ReFlaP working group, PARIS, France'], 'affiliations': [{'raw_affiliation_string': 'ReFlaP working group, PARIS, France', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5045047976', 'display_name': 'Maarten de Wit', 'orcid': 'https://orcid.org/0000-0002-8428-6354'}, 'institutions': [], 'countries': ['FR'], 'is_corresponding': False, 'raw_author_name': 'Maarten de Wit', 'raw_affiliation_strings': ['ReFlaP working group, PARIS, France'], 'affiliations': [{'raw_affiliation_string': 'ReFlaP working group, PARIS, France', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5031590544', 'display_name': 'Clémence Gorlier', 'orcid': 'https://orcid.org/0000-0002-4429-3613'}, 'institutions': [], 'countries': ['FR'], 'is_corresponding': False, 'raw_author_name': 'Clemence Gorlier', 'raw_affiliation_strings': ['ReFlaP working group, PARIS, France'], 'affiliations': [{'raw_affiliation_string': 'ReFlaP working group, PARIS, France', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5039970068', 'display_name': 'Rossana Scrivo', 'orcid': 'https://orcid.org/0000-0002-2889-8962'}, 'institutions': [], 'countries': ['FR'], 'is_corresponding': False, 'raw_author_name': 'Rossana Scrivo', 'raw_affiliation_strings': ['ReFlaP working group, PARIS, France'], 'affiliations': [{'raw_affiliation_string': 'ReFlaP working group, PARIS, France', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5005788294', 'display_name': 'Juan D. Cañete', 'orcid': 'https://orcid.org/0000-0003-2606-0573'}, 'institutions': [], 'countries': ['FR'], 'is_corresponding': False, 'raw_author_name': 'Juan D. Cañete', 'raw_affiliation_strings': ['ReFlaP working group, PARIS, France'], 'affiliations': [{'raw_affiliation_string': 'ReFlaP working group, PARIS, France', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5053075614', 'display_name': 'Penélope Esther Palominos', 'orcid': 'https://orcid.org/0000-0003-0132-4325'}, 'institutions': [], 'countries': ['FR'], 'is_corresponding': False, 'raw_author_name': 'Penelope Palominos', 'raw_affiliation_strings': ['ReFlaP working group, PARIS, France'], 'affiliations': [{'raw_affiliation_string': 'ReFlaP working group, PARIS, France', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5074157226', 'display_name': 'Ying Ying Leung', 'orcid': 'https://orcid.org/0000-0001-8492-6342'}, 'institutions': [], 'countries': ['FR'], 'is_corresponding': False, 'raw_author_name': 'Ying Ying Leung', 'raw_affiliation_strings': ['ReFlaP working group, PARIS, France'], 'affiliations': [{'raw_affiliation_string': 'ReFlaP working group, PARIS, France', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5088736161', 'display_name': 'Ennio Lubrano', 'orcid': 'https://orcid.org/0000-0001-6189-5328'}, 'institutions': [], 'countries': ['FR'], 'is_corresponding': False, 'raw_author_name': 'Ennio Lubrano', 'raw_affiliation_strings': ['ReFlaP working group, PARIS, France'], 'affiliations': [{'raw_affiliation_string': 'ReFlaP working group, PARIS, France', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5052998014', 'display_name': 'Sandra Tälli', 'orcid': None}, 'institutions': [], 'countries': ['FR'], 'is_corresponding': False, 'raw_author_name': 'Sandra Tälli', 'raw_affiliation_strings': ['ReFlaP working group, PARIS, France'], 'affiliations': [{'raw_affiliation_string': 'ReFlaP working group, PARIS, France', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5033879584', 'display_name': 'Andra Bălănescu', 'orcid': 'https://orcid.org/0000-0003-0688-9173'}, 'institutions': [], 'countries': ['FR'], 'is_corresponding': False, 'raw_author_name': 'Andra Balanescu', 'raw_affiliation_strings': ['ReFlaP working group, PARIS, France'], 'affiliations': [{'raw_affiliation_string': 'ReFlaP working group, PARIS, France', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5106824634', 'display_name': 'Uta Kiltz', 'orcid': None}, 'institutions': [], 'countries': ['FR'], 'is_corresponding': False, 'raw_author_name': 'Uta Kiltz', 'raw_affiliation_strings': ['ReFlaP working group, PARIS, France'], 'affiliations': [{'raw_affiliation_string': 'ReFlaP working group, PARIS, France', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5028241466', 'display_name': 'Sibel Zehra Aydın', 'orcid': 'https://orcid.org/0000-0001-8792-4449'}, 'institutions': [], 'countries': ['FR'], 'is_corresponding': False, 'raw_author_name': 'Sibel Aydin', 'raw_affiliation_strings': ['ReFlaP working group, PARIS, France'], 'affiliations': [{'raw_affiliation_string': 'ReFlaP working group, PARIS, France', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5019787392', 'display_name': 'I. Z. Gaydukova', 'orcid': 'https://orcid.org/0000-0003-3500-7256'}, 'institutions': [], 'countries': ['FR'], 'is_corresponding': False, 'raw_author_name': 'Inna Gaydukova', 'raw_affiliation_strings': ['ReFlaP working group, PARIS, France'], 'affiliations': [{'raw_affiliation_string': 'ReFlaP working group, PARIS, France', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5009722499', 'display_name': 'Lihi Eder', 'orcid': 'https://orcid.org/0000-0002-1473-1715'}, 'institutions': [], 'countries': ['FR'], 'is_corresponding': False, 'raw_author_name': 'Lihi Eder', 'raw_affiliation_strings': ['ReFlaP working group, PARIS, France'], 'affiliations': [{'raw_affiliation_string': 'ReFlaP working group, PARIS, France', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5043615700', 'display_name': 'Ana‐Maria Orbai', 'orcid': 'https://orcid.org/0000-0001-8644-8567'}, 'institutions': [], 'countries': ['FR'], 'is_corresponding': False, 'raw_author_name': 'Ana-Maria Orbai', 'raw_affiliation_strings': ['ReFlaP working group, PARIS, France'], 'affiliations': [{'raw_affiliation_string': 'ReFlaP working group, PARIS, France', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5111657027', 'display_name': 'Josef S Smolen', 'orcid': None}, 'institutions': [], 'countries': ['FR'], 'is_corresponding': False, 'raw_author_name': 'Josef S. Smolen', 'raw_affiliation_strings': ['ReFlaP working group, PARIS, France'], 'affiliations': [{'raw_affiliation_string': 'ReFlaP working group, PARIS, France', 'institution_ids': []}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5085522760', 'display_name': 'Laura C. Coates', 'orcid': 'https://orcid.org/0000-0002-4756-663X'}, 'institutions': [], 'countries': ['FR'], 'is_corresponding': False, 'raw_author_name': 'Laura C. Coates', 'raw_affiliation_strings': ['ReFlaP working group, PARIS, France'], 'affiliations': [{'raw_affiliation_string': 'ReFlaP working group, PARIS, France', 'institution_ids': []}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 0, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.211, 'has_fulltext': True, 'fulltext_origin': 'pdf', 'cited_by_count': 1, 'citation_normalized_percentile': {'value': 0.498496, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 61, 'max': 69}, 'biblio': {'volume': None, 'issue': None, 'first_page': '1415.1', 'last_page': '1415'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T11092', 'display_name': 'Spondyloarthritis Studies and Treatments', 'score': 0.998, 'subfield': {'id': 'https://openalex.org/subfields/2745', 'display_name': 'Rheumatology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T11092', 'display_name': 'Spondyloarthritis Studies and Treatments', 'score': 0.998, 'subfield': {'id': 'https://openalex.org/subfields/2745', 'display_name': 'Rheumatology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10200', 'display_name': 'Rheumatoid Arthritis Research and Therapies', 'score': 0.9918, 'subfield': {'id': 'https://openalex.org/subfields/2745', 'display_name': 'Rheumatology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10469', 'display_name': 'Psoriasis: Treatment and Pathogenesis', 'score': 0.9908, 'subfield': {'id': 'https://openalex.org/subfields/2403', 'display_name': 'Immunology'}, 'field': {'id': 'https://openalex.org/fields/24', 'display_name': 'Immunology and Microbiology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [], 'concepts': [{'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.92566746}, {'id': 'https://openalex.org/C2776260265', 'wikidata': 'https://www.wikidata.org/wiki/Q511097', 'display_name': 'Psoriatic arthritis', 'level': 3, 'score': 0.72162694}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.6015659}, {'id': 'https://openalex.org/C2779134260', 'wikidata': 'https://www.wikidata.org/wiki/Q12136', 'display_name': 'Disease', 'level': 2, 'score': 0.5893169}, {'id': 'https://openalex.org/C2780664029', 'wikidata': 'https://www.wikidata.org/wiki/Q5282120', 'display_name': 'Disease burden', 'level': 3, 'score': 0.46382347}, {'id': 'https://openalex.org/C23131810', 'wikidata': 'https://www.wikidata.org/wiki/Q818574', 'display_name': 'Observational study', 'level': 2, 'score': 0.4550165}, {'id': 'https://openalex.org/C30036603', 'wikidata': 'https://www.wikidata.org/wiki/Q17125150', 'display_name': 'Severity of illness', 'level': 2, 'score': 0.4215846}, {'id': 'https://openalex.org/C1862650', 'wikidata': 'https://www.wikidata.org/wiki/Q186005', 'display_name': 'Physical therapy', 'level': 1, 'score': 0.353763}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': True, 'landing_page_url': 'https://doi.org/10.1136/annrheumdis-2019-eular.1206', 'pdf_url': 'https://ard.bmj.com/content/annrheumdis/78/Suppl_2/1415.1.full.pdf', 'source': None, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}], 'best_oa_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1136/annrheumdis-2019-eular.1206', 'pdf_url': 'https://ard.bmj.com/content/annrheumdis/78/Suppl_2/1415.1.full.pdf', 'source': None, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'sustainable_development_goals': [{'display_name': 'Partnerships for the goals', 'score': 0.41, 'id': 'https://metadata.un.org/sdg/17'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 2, 'referenced_works': ['https://openalex.org/W2194197257', 'https://openalex.org/W2901122096'], 'related_works': ['https://openalex.org/W4260738', 'https://openalex.org/W2976382042', 'https://openalex.org/W2895953343', 'https://openalex.org/W2617631585', 'https://openalex.org/W2464797648', 'https://openalex.org/W2357437675', 'https://openalex.org/W2330995418', 'https://openalex.org/W2313076522', 'https://openalex.org/W2129597937', 'https://openalex.org/W1997579941'], 'abstract_inverted_index': {'<h3>Background</h3>': [0], 'The': [1, 402], 'objective': [2, 273], 'of': [3, 33, 47, 60, 70, 101, 108, 116, 141, 182, 275, 310, 321, 335, 342, 374, 380, 395, 405, 412, 417, 424, 448, 455, 498, 529, 551], 'treatment': [4, 400], 'in': [5, 22, 35, 38, 57, 92, 146, 159, 170, 280, 289, 293, 349, 351, 356, 358, 386, 428, 433, 524], 'psoriatic': [6, 499, 525], 'arthritis': [7, 500], '(PsA)': [8], 'is': [9, 26, 133, 410], 'remission': [10, 39, 102, 519], 'or': [11, 40, 103], 'low': [12, 41, 104, 375, 521], 'disease': [13, 34, 71, 74, 109, 148, 191, 206, 254, 276, 300, 363, 397, 425, 436, 449, 476, 522], '(ref1).': [14], 'However,': [15], 'there': [16], 'may': [17], 'remain': [18], 'residual': [19, 299, 371], 'patient': [20, 393], 'burden': [21, 32, 107, 423], 'patients': [23, 37, 63, 158, 350, 357, 531], 'where': [24, 131], 'inflammation': [25], 'controlled.': [27], '<h3>Objectives</h3>': [28], 'To': [29], 'explore': [30], 'patient-perceived': [31, 516], 'PsA': [36, 66, 114, 473], 'disease,': [42, 298], 'when': [43, 258, 469, 475], 'using': [44, 82, 377], 'different': [45], 'definitions': [46, 379, 384], 'remission.': [48], '<h3>Methods</h3>': [49], 'ReFlap': [50], '(NCT03119805,': [51], 'ref2)': [52], 'was': [53, 76, 110, 179, 202, 208, 225, 239, 246, 251, 255, 287, 305, 339, 407, 426, 542], 'an': [54, 527, 547], 'observational': [55], 'study': [56, 541], '14': [58, 533], 'countries': [59], 'consecutive': [61], 'adult': [62], 'with': [64, 303, 472, 501], 'definite': [65], 'and': [67, 89, 121, 127, 138, 166, 193, 218, 248, 291, 337, 361, 388, 517, 520, 567, 584, 633, 650, 676, 690, 734, 741, 748, 755, 768, 776, 846, 864], '&gt;2': [68], 'years': [69], 'duration.': [72], 'Remission/low': [73, 253], 'status': [75, 100, 161, 172, 192, 283, 354], 'defined': [77, 259], 'at': [78], 'the': [79, 113, 134, 281, 392, 413, 429, 434, 452, 456, 496], 'baseline': [80], 'visit': [81], 'composite': [83, 119], 'scores:': [84], 'Minimal': [85], 'Disease': [86, 90, 117, 223], 'Activity': [87, 91], '(MDA),': [88], 'PSoriatic': [93], 'Arthritis': [94], '(DAPSA)&lt;=14': [95], '(both': [96], 'corresponding': [97], 'to': [98, 156, 163, 174, 444], 'a': [99, 215, 221, 316, 324, 332, 399, 445], 'disease).': [105, 295], 'Patient-perceived': [106], 'assessed': [111, 145], 'through': [112, 546], 'Impact': [115], '(PsAID12)': [118], 'score': [120], 'its': [122], 'individual': [123], 'components': [124], 'assessing': [125], 'physical': [126], 'psychological': [128], 'impact': [129, 194, 301, 322, 343, 406, 418], '(0-10': [130], '0': [132], 'optimal': [135], 'status).': [136], 'Mean': [137], 'median': [139, 308, 325, 333], 'levels': [140, 309], 'patient-reported': [142], 'symptoms': [143, 311, 372], 'were': [144, 154, 198, 213, 278, 312, 344, 373], 'remission/low': [147, 297, 396], 'status.': [149], 'P-values': [150], 'by': [151, 260, 266, 420, 544], 'Wilcoxon': [152], 'test': [153], 'computed': [155], 'compare': [157], 'good': [160, 171, 282, 353, 381], 'according': [162, 173], 'both': [164, 359, 378], 'MDA': [165, 290, 360, 389, 430, 442], 'DAPSA': [167, 175, 250], '(n=161),': [168], 'versus': [169], 'only': [176, 329], '(n=90).': [177], 'There': [178], 'no': [180, 230], 'imputation': [181], 'missing': [183], 'data.': [184], '<h3>Results</h3>': [185], 'Of': [186], '466': [187], 'patients,': [188, 264], '444': [189], 'had': [190, 229, 323, 331], 'available:': [195], '220': [196], '(50.5%)': [197], 'male,': [199], 'mean': [200, 205, 235, 241, 249], 'age': [201], '52.2±12.6': [203], 'years,': [204], 'duration': [207], '10.1±8.1': [209], 'years;': [210], '261': [211], '(62.9%)': [212], 'taking': [214], 'conventional': [216], 'DMARD': [217], '255': [219], '(61.3%)': [220], 'biologic.': [222], 'activity': [224, 277, 523], 'moderate:': [226], '154': [227], '(36.2%)': [228], 'current': [231], 'psoriasis': [232], 'skin': [233], 'lesions,': [234], 'tender': [236], 'joint': [237, 243], 'count': [238, 244], '4.7±9.5,': [240], 'swollen': [242], '(SJC)': [245], '2.2±7.0,': [247], '16.6±17.2.': [252], 'more': [256], 'frequent': [257], 'DAPSA:': [261], '251': [262], '(56.5%)': [263], 'than': [265, 355, 432], 'MDA:': [267], '171': [268], '(38.5%)': [269], 'patients.': [270, 421], 'As': [271], 'expected,': [272], 'measures': [274], 'minimal': [279], 'categories': [284], '(e.g.,': [285], 'SJC': [286], '0.3±0.8': [288], '0.4±0.9': [292], 'DAPSA-remission/low': [294, 362, 435], 'In': [296, 367], '(assessed': [302], 'PsAID12)': [304], 'low:': [306], 'most': [307, 414], 'below': [313], '1': [314], 'on': [315], '0-10': [317], 'scale;': [318], '5': [319], 'aspects': [320], 'level': [326, 334], '&gt;=1': [327], '(figure);': [328], 'one': [330, 411], '2,': [336], 'this': [338, 368, 540, 598], 'fatigue.': [340], 'Levels': [341], 'slightly': [345], 'though': [346, 451], 'significantly': [347], 'higher': [348], 'DAPSA-defined': [352], '(all': [364], 'p&lt;0.001).': [365], '<h3>Conclusion</h3>': [366], 'unselected': [369], 'population,': [370], 'magnitude': [376], 'status:': [382], 'DAPSA-based': [383], '(present': [385], '56%)': [387], '(38%),': [390], 'confirming': [391], 'relevance': [394, 454], 'as': [398, 595, 644], 'objective.': [401], 'predominant': [403], 'aspect': [404], 'fatigue,': [408], 'which': [409, 438], 'important': [415], 'domains': [416], 'recognized': [419], 'Residual': [422], 'lower': [427], 'group': [431], 'group,': [437], 'could': [439], 'indicate': [440], 'that': [441], 'corresponds': [443], "'deeper'": [446], 'form': [447], 'control,': [450], 'clinical': [453], 'differences': [457], 'observed': [458], 'should': [459, 466], 'be': [460, 467], 'further': [461], 'explored.': [462], 'A': [463], 'holistic': [464], 'approach': [465], 'implemented': [468], 'evaluating': [470], 'people': [471], 'including': [474], 'control': [477], 'has': [478, 590], 'been': [479], 'obtained.': [480], '<h3>References</h3>': [481], '[1]': [482], 'Gossec': [483, 554, 589], 'L,': [484], 'Smolen': [485, 780], 'JS,': [486], 'et': [487, 513], 'al.': [488, 514], 'European': [489], 'League': [490], 'Against': [491], 'Rheumatism': [492], '(EULAR)': [493], 'recommendations': [494], 'for': [495, 597], 'management': [497], 'pharmacological': [502], 'therapies:': [503], '2015': [504], 'update.': [505], 'Ann': [506, 535], 'Rheum': [507, 536], 'Dis.': [508, 537], '2016;75(3):499-510.': [509], '[2]': [510], 'Gorlier': [511], 'C,': [512], 'Comparing': [515], 'physician-perceived': [518], 'arthritis:': [526], 'analysis': [528], '410': [530], 'from': [532, 593, 646, 712], 'countries.': [534], '2019;78(2):201-208.': [538], '<h3>Acknowledgement</h3>': [539], 'funded': [543], 'Pfizer': [545, 789, 808, 830], 'investigator-initiated': [548], 'grant.': [549], '<h3>Disclosure': [550], 'Interests</h3>': [552], 'Laure': [553], 'Grant/research': [555, 625, 663, 704, 728, 759, 781, 839], 'support': [556, 626, 664, 705, 729, 760, 782, 840], 'from:': [557, 627, 665, 706, 730, 761, 783, 841], 'AbbVie,': [558, 571, 666, 680, 731, 745, 762, 784, 794, 816, 842, 850], 'BMS,': [559, 573, 852], 'Celgene,': [560, 574, 648, 697, 737, 751, 763, 798, 820, 843, 853], 'Janssen,': [561, 575, 671, 685, 739, 753, 766, 773, 787, 804, 826, 858], 'Lilly,': [562, 576, 669, 683, 767, 772, 786, 801, 823, 844, 859], 'MSD,': [563, 577, 672, 686, 718, 788, 806, 828], 'Novartis-Sandoz,': [564, 580, 807, 829], 'Pfizer,': [565, 581, 651, 674, 688, 713, 742, 756, 775, 847, 861], 'Sanofi,': [566, 583, 701, 812, 834], 'UCB,': [568, 585, 698, 738, 752, 777, 813, 835], 'Consultant': [569, 586, 640, 678, 694, 743, 770, 792, 848], 'for:': [570, 587, 641, 679, 695, 744, 771, 793, 849], 'Biogen,': [572], 'Nordic': [578], 'Pharma,': [579, 765], 'Roche,': [582, 675, 689, 791, 810, 832], 'L': [588], 'received': [591], 'honoraria': [592], 'Celgene': [594], 'investigator': [596], 'study,': [599], 'Maarten': [600], 'de': [601], 'Wit:': [602], 'None': [603, 607, 611, 616, 620, 654], 'declared,': [604, 608, 612, 617, 621, 655], 'Clemence': [605], 'Gorlier:': [606], 'Rossana': [609], 'Scrivo:': [610], 'Juan': [613], 'D.': [614], 'Cañete:': [615], 'Penelope': [618], 'Palominos:': [619], 'Ying': [622, 623], 'Leung': [624], 'Abbvie,': [628, 647, 696, 715], 'Novartis,': [629, 634, 637, 673, 687, 699, 714, 740, 754, 769, 774, 860], 'Speakers': [630, 635, 658, 709, 814], 'bureau:': [631, 636, 659, 710, 815], 'Abbvie': [632], 'Ennio': [638], 'Lubrano': [639], 'Consultancy': [642], 'fees': [643], 'speaker': [645], 'Novartis': [649, 845], 'Sandra': [652], 'Tälli:': [653], 'Andra': [656], 'Balanescu': [657], 'multiple,': [660], 'Uta': [661], 'Kiltz': [662], 'Chugai,': [667, 681], 'Eli': [668, 682, 732, 746, 785, 800, 822], 'Grünenthal,': [670, 684], 'UCB.,': [677, 691], 'Sibel': [692], 'Aydin': [693], 'Jannsen,': [700], 'Inna': [702], 'Gaydukova': [703], 'JSC': [707], 'BIOCAD,': [708], 'paiment': [711], 'Biocad,': [716], 'Selgene,': [717], 'Sanofy': [719], 'does': [720], 'not': [721], 'exceed': [722], '10': [723], '000': [724], 'euros,': [725], 'Lihi': [726], 'Eder': [727], 'Lilly': [733, 747], 'Company,': [735, 749], 'Amgen,': [736, 750, 795, 817, 851], 'Ana-Maria': [757], 'Orbai': [758], 'Horizon': [764], 'Josef': [778], 'S.': [779], 'Inc,': [790, 809, 831], 'AstraZeneca,': [796, 818], 'Astro,': [797, 819], 'Celtrion,': [799, 821], 'GlaxoSmithKline,': [802, 824], 'ILTOO,': [803, 825], 'Medimmune,': [805, 827], 'Samsung,': [811, 833], 'Laura': [836], 'C': [837], 'Coates': [838], 'Galapagos,': [854], 'Gilead': [855], 'Sciences': [856], 'Inc.,': [857], 'Prothena': [862], 'Corp': [863], 'UCB': [865]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2954278871', 'counts_by_year': [{'year': 2022, 'cited_by_count': 1}], 'updated_date': '2024-12-17T21:38:19.384528', 'created_date': '2019-07-12'}